However, in the analysis of the 11 prognostic genes expression in the four BRCA stages, significant differential expression of IL33 and JUN were noted, and others had no remarkably difference (Figure 7B, NS, p < 0.01, p < 0.0001). Here, IL33 is linked to invasive breast carcinoma.